|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.53 USD | -0.65% |
|
-4.14% | -28.70% |
| 05-17 | Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors | CI |
| 05-15 | Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call |
Cytokinetics, Incorporated reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 0.835 million compared to USD 4.61 million a year ago. Net loss was USD 135.64 million compared to USD 131.29 million a year ago.
Basic loss per share from continuing operations was USD 1.33 compared to USD 1.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.70% | 6.24B | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
CYTOKINETICS, INCORPORATED 
